Search Result

• All
• Related Products
• Other Content

• Contact Contact Us More+
• Instructions for Use of Human Residual Total RNA Detection Kit (RT-PCR)
• FDA Approves Novartis Gene Therapy Itvisma for Expanded SMA Patient Population Washington, Nov 24, 2025 — The U.S. Food and Drug Administration (FDA) has approved Itvisma, a gene therapy developed by Novartis, for a broader group of patients with spinal muscular atrophy (SMA), ... More+
• Instructions for Use of Human TNF-α ELISA Detection Kit
• Oncolytic Virus CDMO Market Enters Rapid Growth Phase, Expected to Surpass USD 1.7 Billion by 2035 A newly released market report on November 26, 2025 indicates that the global oncolytic virus CDMO services market is entering a phase of accelerated growth. According to the report, the market is pro... More+
• Sitemap More+
• Instructions for Use of Inorganic Pyrophosphatase ELISA Detection Kit
• Genentech to Present 46 Hematology Abstracts at ASH 2025, Including New AAV Gene Therapy and Oncology Data South San Francisco, CA — November 3, 2025 — Biotech leader Genentech announced that it will present 46 abstracts, including 12 oral presentations, from its hematology portfolio at the upcoming ASH ... More+
• Instructions for Use of Kanamycin ELISA Detection Kit
• Regeneron and Tessera Therapeutics Partner to Develop in-Vivo Gene Editing Therapy TSRA-196 for Alpha-1 Antitrypsin Deficiency December 1, 2025 — Regeneron Pharmaceuticals announced today a global collaboration with Tessera Therapeutics to develop and commercialize Tessera’s investigational in-vivo gene editing therapy TSRA... More+
• Privacy Policy This website collects information from our users at several different points on our website in order to process reservations and better serve you with pertinent information. This website is the sole o... More+
• Instructions for Use of Lentiviral Packaging Kit
• Capricor Reports Positive Phase 3 HOPE-3 Results: Deramiocel Demonstrates Skeletal and Cardiac Benefits in Duchenne Muscular Dystrophy December 3, 2025 — Capricor Therapeutics announced that its investigational cell therapy Deramiocel achieved both primary and key secondary endpoints in the pivotal Phase 3 HOPE-3 trial for Duchenne ... More+
• Instructions for Use of Lentivirus Titer p24 ELISA Detection Kit
• Vertex’s Gene Therapy Casgevy Shows Strong Efficacy in Younger Children with Blood Disorders Boston, December 6, 2025Vertex Pharmaceuticals announced new clinical data demonstrating that its gene-editing therapy Casgevy (exagamglogene autotemcel, exa-cel) produced robust therapeutic benefits ... More+